XYL

SEC source: 0001209191-21-041394 · doc4.xml · derivative · entry 5

Toussaint Claudia S · CIK 0001421560 · SVP,CSO,Gen Counsel & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common · 172 shares

Expires 2026-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-21-041394 · doc4.xml · nonDerivative · entry 4

Toussaint Claudia S · CIK 0001421560 · SVP,CSO,Gen Counsel & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,109

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 15, 2021.

F4 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 2,927 Shares were executed at a range of prices from $115.39 to $116.28. 2,169 Shares were executed at a range of prices from $116.70 to $117.68. 685 Shares were executed at a range of prices from $117.70 to $117.93. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

F3 · balance_after: Includes 48,065 shares held by the Claudia S. Toussaint Revocable Trust.

SEC source: 0001209191-21-041394 · doc4.xml · nonDerivative · entry 3

Toussaint Claudia S · CIK 0001421560 · SVP,CSO,Gen Counsel & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,890

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-041394 · doc4.xml · nonDerivative · entry 2

Toussaint Claudia S · CIK 0001421560 · SVP,CSO,Gen Counsel & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,109

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 15, 2021.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

F3 · balance_after: Includes 48,065 shares held by the Claudia S. Toussaint Revocable Trust.

SEC source: 0001209191-21-041394 · doc4.xml · nonDerivative · entry 1

Toussaint Claudia S · CIK 0001421560 · SVP,CSO,Gen Counsel & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,281

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-040550 · doc4.xml · nonDerivative · entry 1

Cerwinka Franz · CIK 0001813828 · SVP and President, Emerging Ma

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,184

F1 · shares: Reflects the sale of common stock to pay the tax liability incident to the vesting of restricted stock units granted on June 12, 2020 under the Xylem 2011 Omnibus Incentive Plan

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

SEC source: 0001209191-21-038869 · doc4.xml · derivative · entry 4

McShane Geri-Michelle · CIK 0001769064 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 747

Underlying: Common · 1,451 shares

Expires 2029-02-20

F3 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on February 20, 2020, February 21, 2021 and February 20, 2022

SEC source: 0001209191-21-038869 · doc4.xml · nonDerivative · entry 3

McShane Geri-Michelle · CIK 0001769064 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,921

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on May 7, 2021.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-21-038869 · doc4.xml · nonDerivative · entry 2

McShane Geri-Michelle · CIK 0001769064 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,454

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on May 7, 2021.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-21-038869 · doc4.xml · nonDerivative · entry 1

McShane Geri-Michelle · CIK 0001769064 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,905

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on May 7, 2021.

SEC source: 0001209191-21-038864 · doc4.xml · nonDerivative · entry 1

Flinton David · CIK 0001654800 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,333

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on May 7, 2021.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 13,953 Shares were executed at a range of prices from $118.38 to $119.26. 13 Shares were executed at a price of $119.38. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-21-037119 · doc4.xml · nonDerivative · entry 1

TAMBAKERAS MARKOS I · CIK 0001012990 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Tambakeras Family Trust

Disclosed balance after: 30,062

F1 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-21-037116 · doc4.xml · derivative · entry 3

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,635

Underlying: Common · 3,604 shares

Expires 2030-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The May 7, 2020 option grant vests in one third increments on February 27, 2021, February 27, 2022 and February 27, 2023.

SEC source: 0001209191-21-037116 · doc4.xml · nonDerivative · entry 2

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,021

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 15, 2021.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). Shares were executed at a range of prices from $118.96 to $119.60. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-21-037116 · doc4.xml · nonDerivative · entry 1

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,625

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-033467 · doc4.xml · derivative · entry 3

Toussaint Claudia S · CIK 0001421560 · SVP,CSO,Gen Counsel & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 172

Underlying: Common · 5,948 shares

Expires 2026-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-21-033467 · doc4.xml · nonDerivative · entry 2

Toussaint Claudia S · CIK 0001421560 · SVP,CSO,Gen Counsel & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,109

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 3,987 Shares were executed at a range of prices from $116.69 to $117.68. 1,961 Shares were executed at a range of prices from $117.69 to $118.22. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

F3 · balance_after: Includes 48,065 shares held by the Claudia S. Toussaint Revocable Trust.

SEC source: 0001209191-21-033467 · doc4.xml · nonDerivative · entry 1

Toussaint Claudia S · CIK 0001421560 · SVP,CSO,Gen Counsel & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,057

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 15, 2021.

SEC source: 0001209191-21-032369 · doc4.xml · nonDerivative · entry 1

TAMBAKERAS MARKOS I · CIK 0001012990 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,575

F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2022 annual shareholders' meeting.

SEC source: 0001209191-21-032373 · doc4.xml · nonDerivative · entry 1

Tretikov Lila · CIK 0001620654 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,729

F1 · shares: Reflects the award of restricted stock units which are scheduled to vest the day before the 2022 Annual Shareowner Meeting.

SEC source: 0001209191-21-032365 · doc4.xml · nonDerivative · entry 1

Peribere Jerome A · CIK 0001484527 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,937

F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2022 annual shareholders' meeting.

F2 · balance_after: Amount shown reflects additional shares acquired via a dividend reinvestment plan or DRIP.

SEC source: 0001209191-21-032374 · doc4.xml · nonDerivative · entry 1

Yadav Uday · CIK 0001479938 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,729

F1 · shares: Reflects the award of restricted stock units which are scheduled to vest on the business day prior to the Xylem Inc. 2022 annual shareholders' meeting.

SEC source: 0001209191-21-032336 · doc4.xml · nonDerivative · entry 1

Harker Victoria D · CIK 0001350579 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,287

F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2022 annual shareholders' meeting.

SEC source: 0001209191-21-032357 · doc4.xml · nonDerivative · entry 1

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,293

F1 · shares: Reflects the award of restricted stock units. The Reporting Person elected to defer the vesting event until separation of service.

SEC source: 0001209191-21-032327 · doc4.xml · nonDerivative · entry 1

FRIEL ROBERT F · CIK 0001224110 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,735

F1 · shares: Reflects the award of restricted stock units. The Reporting Person elected to defer the vesting of the RSU Award until January 1, 2026.

F2 · balance_after: Amount shown reflects additional shares acquired via a dividend reinvestment plan or DRIP.

SEC source: 0001209191-21-032362 · doc4.xml · nonDerivative · entry 1

MOHAPATRA SURYA N · CIK 0001222671 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,152

F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2022 annual shareholders' meeting.

SEC source: 0001209191-21-032376 · doc4.xml · nonDerivative · entry 1

Yarkadas Hayati · CIK 0001657363 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,369

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 25, 2021.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

SEC source: 0001209191-21-032344 · doc4.xml · nonDerivative · entry 1

Gomez Jorge M · CIK 0001726653 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,758

F1 · shares: Reflects the award of restricted stock units. The Reporting Person elected to defer the vesting of the RSU Award until Separation from Service.

F2 · balance_after: Amount shown reflects additional shares acquired via a dividend reinvestment plan or DRIP.

SEC source: 0001209191-21-032323 · doc4.xml · nonDerivative · entry 1

Beliveau-Dunn Jeanne · CIK 0001714894 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,332

F1 · shares: Reflects the award of restricted stock units. The Reporting Person elected to defer the vesting of the RSU Award until Separation from Service.

SEC source: 0001209191-21-032317 · doc4.xml · nonDerivative · entry 1

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,021

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 15, 2021.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). Shares were executed at a price of $117.4673. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-21-032313 · doc4.xml · nonDerivative · entry 1

Jakobsson Sten E · CIK 0001532863 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,498

F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incidental to the vesting of stock-settled restricted stock units.

SEC source: 0001209191-21-031850 · doc4.xml · nonDerivative · entry 1

Beliveau-Dunn Jeanne · CIK 0001714894 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,004

F1 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

F2 · balance_after: Includes additional shares due to Dividend Reinvestment.

SEC source: 0001209191-21-031852 · doc4.xml · derivative · entry 5

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,239

Underlying: Common · 3,604 shares

Expires 2030-02-27

F5 · derivative.exercise_date: The May 7, 2020 stock option grant is scheduled to vest in one third increments on February 27, 2021, February 27, 2022 and February 27, 2023

SEC source: 0001209191-21-031852 · doc4.xml · nonDerivative · entry 4

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,824

F2 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 15, 2021.

F4 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 505 Shares were executed at a range of prices from $117.99 to $118.46. 529 shares were executed at a range of prices from $119.11 to $119.33. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-21-031852 · doc4.xml · nonDerivative · entry 3

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,858

F2 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 15, 2021.

F3 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,583 Shares were executed at a range of prices from $118.05 to $118.67. 2,021 shares were executed at a range of prices from $119.06 to $119.45. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-21-031852 · doc4.xml · nonDerivative · entry 2

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,462

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-031852 · doc4.xml · nonDerivative · entry 1

Pine Matthew Francis · CIK 0001807057 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,858

F1 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on May 7, 2020 under the Xylem 2011 Omnibus Incentive Plan

SEC source: 0001209191-21-031855 · doc4.xml · derivative · entry 10

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,206

Underlying: Common · 1,897 shares

Expires 2027-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-21-031855 · doc4.xml · derivative · entry 9

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,103

Underlying: Common · 503 shares

Expires 2027-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-21-031855 · doc4.xml · derivative · entry 8

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common · 1,397 shares

Expires 2026-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-21-031855 · doc4.xml · nonDerivative · entry 7

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,075

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020.

F5 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). Shares were executed at a range of prices from $118.05 to $119.36. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

SEC source: 0001209191-21-031855 · doc4.xml · nonDerivative · entry 6

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,871

F4 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). Shares were executed at a range of prices from $118.05 to $119.37. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

SEC source: 0001209191-21-031855 · doc4.xml · nonDerivative · entry 5

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,768

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020.

SEC source: 0001209191-21-031855 · doc4.xml · nonDerivative · entry 4

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,871

F3 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

SEC source: 0001209191-21-031855 · doc4.xml · nonDerivative · entry 3

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,374

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020.

SEC source: 0001209191-21-031855 · doc4.xml · nonDerivative · entry 2

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,871

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). Shares were executed at a range of prices from $118.05 to $119.37. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

SEC source: 0001209191-21-031855 · doc4.xml · nonDerivative · entry 1

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,268

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020.

SEC source: 0001209191-21-031851 · doc4.xml · nonDerivative · entry 1

Yarkadas Hayati · CIK 0001657363 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,980

F1 · shares: Reflects the sale of common stock to pay the tax liability incident to the vesting of restricted stock units granted on May 7, 2020 under the Xylem 2011 Omnibus Incentive Plan

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

SEC source: 0001209191-21-026945 · doc4.xml · derivative · entry 3

Toussaint Claudia S · CIK 0001421560 · SVP,CSO,Gen Counsel & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,120

Underlying: Common · 5,948 shares

Expires 2026-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-21-026945 · doc4.xml · nonDerivative · entry 2

Toussaint Claudia S · CIK 0001421560 · SVP,CSO,Gen Counsel & Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,109

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 5,948 Shares were executed at a range of prices from $107.17 to $108.11. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

F3 · balance_after: Includes 48,065 shares held by the Claudia S Toussaint Revocable Trust. 4,596 shares were transferred to the Claudia S Toussaint Revocable Trust on March 16, 2021.